BioMed Central | Articles which cite: Identification of candidate predictive and surrogate molecular markers for dasatinib in prostate cancer: rationale for patient selection and efficacy monitoring.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Kinase-dependent and -independent roles of EphA2 in the regulation of prostate cancer invasion and metastasis. Taddei ML, Parri M, Angelucci A, Onnis B, Bianchini F, Giannoni E, Raugei G, Calorini L, Rucci N, Teti A, Bologna M, Chiarugi P Am J Pathol 2009 Apr, 174:1492-503 [PubMed Central] [PubMed] [Related articles]
2.	Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer. Chang Q, Jorgensen C, Pawson T, Hedley DW Br J Cancer 2008 Oct 7, 99:1074-82 [PubMed Central] [PubMed] [Related articles]
3.	Transcriptional profiling of the dose response: a more powerful approach for characterizing drug activities. Ji RR, de Silva H, Jin Y, Bruccoleri RE, Cao J, He A, Huang W, Kayne PS, Neuhaus IM, Ott KH, Penhallow B, Cockett MI, Neubauer MG, Siemers NO, Ross-Macdonald P PLoS Comput Biol 2009 Sep, 5:e1000512 [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)

printer friendly

to [Help]